|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments for items not affecting cash: | |||||
| Depreciation and amortization | |||||
| Share-based payments expense | |||||
| Deferred income taxes | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Gain on disposition of property, plant and equipment | |||||
| Loss on divestiture and deconsolidation, net | |||||
| Allowance for expected credit losses | |||||
| Loss on redemption of notes | |||||
| Amortization of debt issuance costs | |||||
| Amortization of right-of-use assets | |||||
| Other, net | |||||
| Net changes in operating assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Divestiture, net of cash transferred | |||||
| Property, plant and equipment additions | |||||
| Proceeds on disposition of property, plant and equipment | |||||
| Intangible asset additions | |||||
| Repayment of loans receivable | |||||
| Issuance of loans receivable | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Issuance of common stock and preferred stock, net of issuance costs | |||||
| Dividends paid to common stockholders | |||||
| Acquisition of remaining interest in NCI and dividends paid to NCI | |||||
| Dividends paid to Series A Senior Preferred shareholders | |||||
| Dividends paid | |||||
| Proceeds from exercise of options and employee stock purchase plan | |||||
| Payment of withholding taxes on issuance of shares | |||||
| Net increase (decrease) in short-term debt | |||||
| Proceeds from long-term debt | |||||
| Repayment of long-term debt | |||||
| Payment of debt issue costs | |||||
| Repayment of finance lease and equipment financing obligations | |||||
| Proceeds of equipment financing obligations | |||||
| Payment of contingent consideration | |||||
| Net cash used in provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
Loading...